Clinical Trials Logo
  1. Home
  2. Adverse Drug Events
  3. NCT04692220
  4. Details
NCT04692220 Clinical Trial

Drug-Related Problems : Focus on Age and Diabetes

Adverse Drug Events Clinical Trial

— DRP-AD  

Official title:
Observatory of Drug-Related Problems: Impact of the Age and the Presence of Diabetes

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04692220
Other study ID # RECHMPL20_0667
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2011
Est. completion date March 30, 2021

Study information
Verified date October 2021
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Drug-Related Problems (DRP) are a variety of events or circumstances that can interfere with the expected results of a treatment. They may be due to the drug itself, its association with other treatments, its incompatibility with the patient, its misuse... When these situations result in harm, they are referred to as adverse drug events (ADEs). DRP and particularly ADE represent a major public health problem in healthcare institutions because of their impact on morbidity and health costs. DRPs are largely preventable and actions can be set up to detect and correct them. It is in this context that clinical pharmacy has expanded, with the development of new activities to help secure drug management. In our institution, the investigators have implemented several activities in different care services, including - medication reconciliation, - an ADE detection. These activities have interesting and encouraging results in terms of impact on the prevention of DRP. However, they can only be carried out on a limited number of patients, depending on the pharmaceutical resources available. The investigators therefore need tools to prioritize our activities on the most at-risk patients. In this study, the investigators seek to identify DRP risk factors and develop DRP risk scores, with the objective to improve the detection and even prevention of DRP. Translated with www.DeepL.com/Translator (free version)

Recruitment information / eligibility
Status Completed
Enrollment 27000
Est. completion date March 30, 2021
Est. primary completion date March 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria: - Patients aged above 18 years old, admitted to the emergency department or hospital Exclusion criteria: - Patients presenting acute psychological disturbance - Patients that did not agree to participate

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Detection of Adverse Drug Events or Drug-Related Problems
Detection of Adverse Drug Events or Drug-Related Problems

Locations
Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems 1 day
Secondary Number and type of Adverse Drug Events and Drug-Related Problems Number and type of Adverse Drug Events and Drug-Related Problems 1 day
See also
  Status Clinical Trial Phase
Completed NCT02239237 - Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Completed NCT01179867 - Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge N/A
Completed NCT02191358 - YouScript IMPACT Registry N/A
Completed NCT02059044 - Information Systems-enabled Outreach Program for Adverse Drug Events N/A
Completed NCT01164137 - Eliminating Risk of Preventable Adverse Drug Events at the Hospital-community Interface of Care N/A
Completed NCT02482025 - The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial N/A
Completed NCT02378220 - Pharmacogenetic Testing Among Home Health Patients N/A
Completed NCT01337063 - Multi-Center Medication Reconciliation Quality Improvement Study N/A
Completed NCT02593916 - Response to Medication Registry
Completed NCT00013143 - Patient Profiling and Provider Feedback to Reduce Adverse Drug Events N/A
Withdrawn NCT00606606 - Reducing Adverse Drug Events in the Nursing Home N/A
Completed NCT02026453 - Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy N/A
Completed NCT02805270 - Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization N/A
Completed NCT01764204 - Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years N/A
Completed NCT01531088 - Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes N/A
Completed NCT02122965 - The Effect of Medication Review in High-risk Emergency Department Patients N/A
Completed NCT00780572 - Implementation of Real-time ADE Surveillance and Decision Support N/A
Completed NCT01091038 - Improving Safety by Basic Computerizing Outpatient Prescribing Phase 2/Phase 3
Recruiting NCT04479553 - Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
Active, not recruiting NCT00740675 - Ambulatory Medication Reconciliation Following Hospital Discharge N/A